+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose



Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose



Nutrition Journal 8: 22



To provide an initial evaluation of insulin sensitivity and secretion indices derived from a standard liquid meal tolerance test protocol in subjects with normal (NFG), impaired fasting glucose (IFG) or type 2 diabetes mellitus. Areas under the curve (AUC) for glucose, insulin and C-peptide from pre-meal to 120 min after consumption of a liquid meal were calculated, as were homeostasis model assessments of insulin resistance (HOMA2-IR) and the Matsuda index of insulin sensitivity. Subjects with NFG (n = 19), IFG (n = 19), and diabetes (n = 35) had mean +/- SEM HOMA2-IR values of 1.0 +/- 0.1, 1.6 +/- 0.2 and 2.5 +/- 0.3 and Matsuda insulin sensitivity index values of 15.6 +/- 2.0, 8.8 +/- 1.2 and 6.0 +/- 0.6, respectively. The log-transformed values for these variables were highly correlated overall and within each fasting glucose category (r = -0.91 to -0.94, all p < 0.001). Values for the product of the insulin/glucose AUC ratio and the Matsuda index, an indicator of the ability of the pancreas to match insulin secretion to the degree of insulin resistance, were 995.6 +/- 80.7 (NFG), 684.0 +/- 57.3 (IFG) and 188.3 +/- 16.1 (diabetes) and discriminated significantly between fasting glucose categories (p < 0.001 for each comparison). These results provide initial evidence to support the usefulness of a standard liquid meal tolerance test for evaluation of insulin secretion and sensitivity in clinical and population studies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053814108

Download citation: RISBibTeXText

PMID: 19476649

DOI: 10.1186/1475-2891-8-22


Related references

Repeatability of indices of insulin sensitivity and secretion from standard liquid meal tests in subjects with type 2 diabetes mellitus or normal or impaired fasting glucose. Diabetes Technology and Therapeutics 12(11): 895-900, 2010

Comparison of insulin secretion and insulin sensitivity between normal and impaired glucose tolerance subjects with normal fasting plasma glucose. Zhonghua Yi Xue Za Zhi 46(2): 73-78, 1990

Assessment of insulin sensitivity and secretion indices from oral glucose tolerance testing in subjects with fasting euglycemia but impaired 2-hour plasma glucose. Metabolism: Clinical and Experimental 52(11): 1523-4; Discussion 1524-5, 2003

Insulin sensitivity and secretion indices in Japanese subjects with normal and impaired glucose tolerance. Diabetology International 3(2): 80-85, 2012

Insulin secretion and insulin sensitivity in Japanese subjects with impaired fasting glucose and isolated fasting hyperglycemia. Diabetes Research and Clinical Practice 70(1): 46-52, 2005

Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care 26(3): 868-874, 2003

Insulin secretion and insulin sensitivity in subjects with impaired fasting glucose. Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl. 2): 151-154, 2005

Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. Diabetes Care 27(6): 1439-1446, 2004

Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care 32(3): 439-444, 2009

Evaluation of the safety, efficacy and tolerability of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset Type 2 diabetes. Diabetes & Metabolism 29(Hors serie 2): 4S230, 2003

A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes. Experimental and Clinical Endocrinology and Diabetes 116(5): 282-288, 2008

Insulin action and secretion in subjects with normal or impaired fasting glucose. Diabetes 52(Suppl. 1): A285, 2003

Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes. Metabolism: Clinical and Experimental 53(12): 1552-1557, 2004

The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance. American Journal of Physiology. Endocrinology and Metabolism 295(2): E401-E406, 2008

Comparison of the metabolic effects of mixed meal and standard oral glucose tolerance test on glucose insulin and c peptide response in healthy impaired glucose tolerance mild and severe non insulin dependent diabetic subjects. Acta Diabetologica 29(1): 29-33, 1992